This is individual research and does not constitute investment advice.
It’s been almost six months since adult-use sales began in Canada.
And we’re a little more than six months away from edibles and infused product sales kicking off nationwide.
This is the market I’ve been telling investors to prepare for.
That’s because the potential could be several times that of the smoking or vaping markets. We already know dried flower sales fall significantly once the door is opened to infused products. And that’s because consumers are far more likely to have a drink, candy, gummies or a brownie than they are to smoke.
That’s why I’m excited to have OrganiGram Holdings (OTC: OGRMF) CEO Greg Engel as my guest on today’s episode of CannaBiz Now!
He talks about how the licensed producer is preparing for the edibles and infused product market launching in Canada later this year.
OrganiGram may not be a household name in the cannabis space. But it is a company every serious cannabis investor should be aware of.
In the last quarter, OrganiGram produced more product than either Canopy Growth Corp. (NYSE: CGC) or Aurora Cannabis (NYSE: ACB). And in the quarter, the company reported a $0.56 cost per gram – the lowest anyone in the industry has reported.
Engel shares how his company has been able to achieve this success with much less space than its competitors have. He also tells us about the company’s plans for growth and expansion.
This is an interview you can’t afford to miss!